Clinical Trial

Effect of Acute Endurance Exercise on the Production of FGF21 and Follistatin in Patients With Hepatocellular Carcinoma

Study acronym: ECHEF
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The main purpose of the study is to characterize the production of hepatokines (FGF21 and Follistatin) in response to a submaximal exercise on an ergocycle, in patients with hepatocellular carcinoma. The effect of exercise on hepatokines and metabolites production in liver cancer patients is not known. Studying this production could help to provide relevant recommendations for training programming in these patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-19.
Trial Details
NCT Number NCT07189624
Lead Sponsor University Hospital, Clermont-Ferrand
Conditions Cirrhosis With Hepatocellular Carcinoma
Enrollment 12 participants
Start Date 2025-12
Primary Completion 2028-04 (estimated)
Study Completion 2029-04 (estimated)
Updated on ClinicalTrials.gov 2025-12-31